2015

Below you can find publications from the CHOICE Project and other studies completed by our research team.  Clicking on the article title will navigate to the full abstract.  For other years, please use the navigation menu on the left.

2015

Young age, nulliparity, and continuation of long-acting reversible contraceptive methods

Abraham M, Zhao Q, Peipert JF. Obstet Gynecol. 2015 Oct;126(4):823-9.

Long-term utilization and continuation of intrauterine devices

Diedrich JT, Madden T, Zhao Q, Peipert JF. Am J Obstet Gynecol. 2015 Dec;213(6):822.e1-6. Epub 2015 Sep 25.

Three-year continuation of reversible contraception

Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. Epub 2015 Aug 7.

Adolescent experiences with intrauterine device: a qualitative study

Schmidt EO, James A, Curran KM, Peipert JF, Madden T. J Adolesc Health. 2015 Oct;57(4):381-6. Epub 2015 Jun 27.

Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion

Grentzer JM, Peipert JF, Zhao Q, McNicholas C, Secura GM, Madden T. Contraception. 2015 Oct;92(4):313-8. Epub 2015 Jun 17.

Pharmacy claims data versus patient self-report to measure contraceptive method continuation

Triebwasser JE, Higgins S, Secura GM, Zhao Q, Peipert JF. Contraception. 2015 Jul;92(1):26-30. Epub 2015 Apr 7.

Fertility after intrauterine device removal: a pilot study

Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Eur J Contracept Reprod Health Care. 2015 Jun;20(3):223-30. Epub 2015 Mar 9.

Positive testing for Neisseria gonorrhoaeae and Chalmydia trachomatis and the risk of pelvic inflammatory disease in IUD users

Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Eur J Contracept Reprod Health Care. 2015 Jun;20(3):223-30. Epub 2015 Mar 9.

Preventing unintended pregnancy: The Contraceptive CHOICE Project in review

Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. J Womens Health (Larchmt). 2015 May;24(5):349-53. Epub 2015 Mar 31.

Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration – approved duration

McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert JF. Obstet Gynecol. 2015 Mar;125(3):599-604.

The role of contraceptive attributes in women’s contraceptive decision making

Madden T, Secura GM, Nease RF, Politi MC, Peipert JF. Am J Obstet Gyencol. 2015 Jul;213(1):46.e1-6. Epub 2015 Jan 30.